Antibacterial use in the age of SARS-CoV-2.

Angell, Kathleen E; Lawler, James V; Hewlett, Angela L; Rupp, Mark E; Bergman, Scott J; Van Schooneveld, Trevor C; Broadhurst, M Jana; Brett-Major, David M

Angell, Kathleen E; Lawler, James V; Hewlett, Angela L; Rupp, Mark E; Bergman, Scott J; Van Schooneveld, Trevor C; Broadhurst, M Jana; Brett-Major, David M.

Afiliación

Angell KE; Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA.
Lawler JV; Global Center for Health Security, University of Nebraska Medical Center, Omaha, NE, USA.
Hewlett AL; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Rupp ME; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Bergman SJ; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Van Schooneveld TC; Antimicrobial Stewardship Program, Nebraska Medicine, Omaha, NE, USA.
Broadhurst MJ; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Brett-Major DM; Global Center for Health Security, University of Nebraska Medical Center, Omaha, NE, USA.

JAC Antimicrob Resist ; 3(2): dlab073, 2021 Jun.

Article en En | MEDLINE | ID: mdl-34223134

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: JAC Antimicrob Resist Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google